Profiles in Pharma - March 8, 2017
“We have to embrace the new era of diabetes care”
Mads Krogsgaard Thomsen, Executive Vice President and Chief Science Officer at Novo Nordisk, talks about the Danish pharma giant’s drug-development strategy, the new era of diabetes care and his 25 year-long passion for his job. The changing diabetes market, with increasing competition and high prices for diabetes products in the US, has made the world’s […]
Pharma article - April 15, 2016
Tackling diabetes
Much effort is being made to develop new medicines for diabetes and recent findings indicate the potential for new and improved pharmaceuticals. Diabetes is one of the largest global diseases and there is a huge unmet need for efficient medicines. The firsthand medication for type 2 diabetes has long been the oral drug metformin. Glitazones […]
Uncategorized - February 22, 2016
Genetic mutations prevent diabetes complications
A Finnish study has identified two genetic mutations that appear to lower the risk of contracting a diabetic retinal or kidney disease. Known as retinopathy and nephropathy respectively, these are the most significant complications associated with diabetes. Both involve damaged capillaries and are primarily a result of high blood sugar, along with genetic factors. Experiments indicate […]
Collaboration - July 7, 2015
Astra Forms New Partnerships
AstraZeneca is involved in two new projects that focus on heart disease and respiratory illness. The company is partnering with the Montreal Heart Institute, which will search the genomes of up to 80,000 patients for genes associated with cardiovascular diseases and diabetes. AstraZeneca also has reached a new deal with Abbott Laboratories for a diagnostic […]
Uncategorized - March 26, 2015
Diabetic Pancreas Cells Recover
Pancreases of patients with type 1 diabetes can regain the ability to produce insulin when cells are given the chance to recover outside the body, researchers have demonstrated. Professor Knut Dahl-Jørgensen and doctoral student Lars Krogvold at the University of Oslo are leading a research project (DiViD) to try to determine, among other things, if […]
In a new job - March 26, 2015
Mendor Names Medical Director
Diabetes researcher Dr. Antonio Ceriello has been named medical director of Finnish company Mendor. Currently Professor Ceriello is head of the Research Department on Diabetes and CVD at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain and is the president of the European Association for the Study of Diabetes Study Group on […]
